Publications | Lund University Publications

1 – 9 of 9

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=keywords+exact+%22Lenalidomide%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2023
Mark Secondary malignancies among mantle cell lymphoma patients
Abalo, Kossi D. ; Smedby, Karin E. ; Ekberg, Sara ^LU ; Eloranta, Sandra ; Pahnke, Simon ; Albertsson-Lindblad, Alexandra ^LU ; Jerkeman, Mats ^LU and Glimelius, Ingrid (2023) In European Journal of Cancer 195.
- Contribution to journal › Article
2021
Mark Newly diagnosed and relapsed follicular lymphoma : ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Dreyling, M. ; Ghielmini, M. ; Rule, S. ; Salles, G. ; Ladetto, M. ; Tonino, S. H. ; Herfarth, K. ; Seymour, J. F. and Jerkeman, M. ^LU (2021) In Annals of oncology : official journal of the European Society for Medical Oncology 32(3). p.298-308
- Contribution to journal › Article
2020
Mark Second malignancies in multiple myeloma; emerging patterns and future directions
Maclachlan, Kylee ; Diamond, Benjamin ; Maura, Francesco ; Hillengass, Jens ; Turesson, Ingemar ^LU ; Landgren, C. Ola and Kazandjian, Dickran (2020) In Best Practice and Research: Clinical Haematology 33(1).
- Contribution to journal › Scientific review
2019
Mark Ibrutinib inhibits antibody dependent cellular cytotoxicity induced by rituximab or obinutuzumab in MCL cell lines, not overcome by addition of lenalidomide
Albertsson-Lindblad, Alexandra ^LU ; Freiburghaus, Catja ^LU ; Jerkeman, Mats ^LU and Ek, Sara ^LU (2019) In Experimental Hematology and Oncology 8(1).
- Contribution to journal › Article
2018
Mark Mantle cell lymphoma strategies in primary treatment
Albertsson Lindblad, Alexandra ^LU (2018) In Lund University, Faculty of Medicine Doctoral Dissertation Series 2018(28).
- Thesis › Doctoral thesis (compilation)
Mark Lenalidomide versus lenalidomide + dexamethasone prolonged treatment after second-line lenalidomide + dexamethasone induction in multiple myeloma
Lund, Johan ; Gruber, Astrid ; Lauri, Birgitta ; Duru, Adil Doganay ; Blimark, Cecilie ; Swedin, Agneta ; Hansson, Markus ^LU ; Forsberg, Karin ; Ahlberg, Lucia and Carlsson, Conny , et al. (2018) In Cancer Medicine 7(6). p.2256-2268
- Contribution to journal › Article
2014
Mark Outcomes in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with isolated deletion 5q treated with lenalidomide: a subset analysis from the MDS-004 study
Giagounidis, Aristoteles ; Mufti, Ghulam J. ; Mittelman, Moshe ; Sanz, Guillermo ; Platzbecker, Uwe ; Muus, Petra ; Selleslag, Dominik ; Beyne-Rauzy, Odile ; te Boekhorst, Peter and del Canizo, Consuelo , et al. (2014) In European Journal of Haematology 93(5). p.429-438
- Contribution to journal › Article
2011
Mark Clinical effect of increasing doses of lenalidomide in high-risk myelodysplastic syndrome and acute myeloid leukemia with chromosome 5 abnormalities
Mollgard, Lars ; Saft, Leonie ; Treppendahl, Marianne Bach ; Dybedal, Ingunn ; Norgaard, Jan Maxwell ; Astermark, Jan ^LU ; Ejerblad, Elisabeth ; Garelius, Hege ; Dufva, Inge Hogh and Jansson, Monika , et al. (2011) In Haematologica 96(7). p.963-971
- Contribution to journal › Article
2008
Mark Prevention of thalidomide- and lenalidomide-associated thrombosis in myeloma
Palumbo, A. ; Rajkumar, S. V. ; Dimopoulos, M. A. ; Richardson, P. G. ; Miguel, J. San ; Barlogie, B. ; Harousseau, J. ; Zonder, J. A. ; Cavo, M. and Zangari, M. , et al. (2008) In Leukemia 22(2). p.414-423
- Contribution to journal › Article

your query:: Remove keywords: Lenalidomide